Ageing and the brain

Journal of Pathology

Volumn 211, Issue 2, 2007, Pages 181-187

  Esiri, Margaret M ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Advanced glycation end products (AGEs); Ageing; Calcium homeostasis; Human brain; Oxidative damage

Indexed keywords

CALCIUM; CYANOCOBALAMIN; FOLIC ACID; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDOXINE;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN DISEASE; BRAIN RADIOGRAPHY; BRAIN WEIGHT; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CALORIC RESTRICTION; CELL LOSS; CELL METABOLISM; CELL POPULATION; CELL SIZE; CREUTZFELDT JAKOB DISEASE; DENDRITIC CELL; DNA DAMAGE; ENVIRONMENTAL FACTOR; EXERCISE; FAT INTAKE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC RISK; GERIATRIC DISORDER; GLYCATION; HISTOPATHOLOGY; HUMAN; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

AGING; APOLIPOPROTEINS E; BRAIN; CALCIUM; CALORIC RESTRICTION; ENERGY METABOLISM; ENVIRONMENT; GLYCOSYLATION END PRODUCTS, ADVANCED; HOMEOSTASIS; HUMANS; NEURONS; OXIDATIVE STRESS; PRIONS;

EID: 33846672434     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2089     Document Type: Review

References (98)

1. Miller AK, Corsellis JA. Evidence for a secular increase in human brain weight during the past century. Ann Hum Biol 1977;4:253-257.
2. Dekaban AS. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978;4:345-356.
3. Ho KC, Roessmann U, Straumfjord JV, Monroe G. Analysis of brain weight. I. Adult brain weight in relation to sex, race, and age. Arch Pathol Lab Med 1980;104:635-639.
4. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85 year-olds. N Engl J Med 1993;328:153-158.
5. Fox NC, Schott JM. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 2004;363:392-394.
6. Blinkov S, Glezer I. The Human Brain in Figures and Tables: A Quantitative Handbook. Plenum: New York, 1968.
7. Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992;42:527-536.
8. Jernigan TL, Press GA, Hesselink JR. Methods for measuring brain morphologic features on magnetic resonance images. Validation and normal aging. Arch Neurol 1990;47:27-32.
9. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994;51:874-887.
10. Raz N. The ageing brain: structural changes and their implications for cognitive ageing. In New Frontiers in Cognitive Ageing, Dixon R, Backman L, Nilsson L (eds). Oxford University Press: Oxford, 2004; 115-134.
11. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 2003;23:3295-3301.
12. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003;60:989-994.
13. Trollor JN, Valenzuela MJ. Brain ageing in the new millennium. Aust NZ J Psychiatr 2001;35:788-805.
14. Esiri M. Dementia and normal aging: neuropathology. In Dementia and Normal Aging, Huppert F, Brayne C, O'Connor D (eds). Cambridge University Press: Cambridge, 1994; 385-436.
15. Brody H. Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. J Comp Neurol 1955;102:511-516.
16. Henderson G, Tomlinson BE, Gibson PH. Cell counts in human cerebral cortex in normal adults throughout life using an image analysing computer. J Neurol Sci 1980;46:113-136.
17. Ball MJ. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol (Berl) 1977;37:111-118.
18. Hall T, Miller K, Corsellis JA. Variations in the human Purkinje cell population according to age and sex. Neuropathol Appl Neurobiol 1975;1:267-292.
19. Benes FM, Lange N. Two-dimensional versus three-dimensional cell counting: a practical perspective. Trends Neurosci 2001;24:11-17.
20. Howard C, Reed M. Unbiased Stereology: Three-dimensional Measurement in Microscopy. Bios Scientific: London, 1998.
21. West MJ. New stereological methods for counting neurons. Neurobiol Aging 1993;14:275-285.
22. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci 1999;22:51-61.
23. Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 2004;27:607-613.
24. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-772.
25. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-175.
26. Gazzaley AH, Thakker MM, Hof PR, Morrison JH. Preserved number of entorhinal cortex layer II neurons in aged macaque monkeys. Neurobiol Aging 1997;18:549-553.
27. Keuker JI, Luiten PG, Fuchs E. Preservation of hippocampal neuron numbers in aged rhesus monkeys. Neurobiol Aging 2003;24:157-165.
28. Merrill DA, Roberts JA, Tuszynski MH. Conservation of neuron number and size in entorhinal cortex layers II, III, and V/VI of aged primates. J Comp Neurol 2000;422:396-401.
29. Peters A, Leahu D, Moss MB, McNally KJ. The effects of aging on area 46 of the frontal cortex of the rhesus monkey. Cereb Cortex 1994;4:621-635.
30. Smith DE, Rapp PR, McKay HM, Roberts JA, Tuszynski MH. Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons. J Neurosci 2004;24:4373-4381.
31. Anderson JM, Hubbard BM, Coghill GR, Slidders W. The effect of advanced old age on the neurone content of the cerebral cortex. Observations with an automatic image analyser point counting method. J Neurol Sci 1983;58:235-246.
32. Haug H. Are neurons of the human cerebral cortex really lost during ageing? A morphometric examination. In Senile Dementia of the Alzheimer Type, Traber J, Gispen W (eds). Springer: Berlin, 1985; 150-163.
33. Meier-Ruge W, Iwangoff P, Reichlmeier K, Sandoz P. Neurochemical findings in the aging brain. Adv Biochem Psychopharmacol 1980;23:323-338.
34. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 1987;21:530-539.
35. Buell SJ, Coleman PD. Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementia. Brain Res 1981;214:23-41.
36. Jacobs B, Driscoll L, Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol 1997;386:661-680.
37. Chance SA, Casanova MF, Switala AE, Crow TJ, Esiri MM. Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing. Acta Neuropathol (Berl) 2006;111:459-464.
38. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997;56:1269-1275.
39. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5:863-873.
40. Schmitt HP. ε-Glycation, APP and Aβ in ageing and Alzheimer disease: a hypothesis. Med Hypotheses 2006;66:898-906.
41. Esiri MM. The interplay between inflammation and neurodegeneration in CNS disease. J Neuroimmunol 2006;(in press).
42. Mann DM, Yates PO, Stamp JE. The relationship between lipofuscin pigment and ageing in the human nervous system. J Neurol Sci 1978;37:83-93.
43. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006;441:885-889.
44. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nat Rev Neurosci 2006;7:30-40.
45. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT. a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-594.
46. Toescu EC. Normal brain ageing: models and mechanisms. Phil Trans R Soc Lond B Biol Sci 2005;360:2347-2354.
47. Stadtman ER. Protein oxidation and aging. Science 1992;257:1220-1224.
48. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
49. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004;429:883-891.
50. Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002;23:795-807.
51. Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. Neurosci Lett 1996;208:53-56.
52. Kimura T, Takamatsu J, Miyata T, Miyakawa T, Horiuchi S. Localization of identified advanced glycation end-product structures, N-ε (carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains. Pathol Int 1998;48:575-579.
53. Chen F, Wollmer MA, Hoerndli F, Munch G, Kuhla B, Rogaev EI, et al. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci USA 2004;101:7687-7692.
54. Thornalley PJ. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003;31:1343-1348.
55. 2+ homeostasis in aged cerebellar granule neurons in brain slices. J Neurosci 2002;22:10761-10771.
56. 2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci 2001;21:9744-9756.
57. Cowan CM, Thai J, Krajewski S, Reed JC, Nicholson DW, Kaufmann SH, et al. Caspases 3 and 9 send a pro-apoptotic signal from synapse to cell body in olfactory receptor neurons. J Neurosci 2001;21:7099-7109.
58. Gilman CP, Mattson MP. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromol Med 2002;2:197-214.
59. Sagot Y, Dubois-Dauphin M, Tan SA, de Bilbao F, Aebischer P, Martinou JC, et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 1995;15:7727-7733.
60. Gillingwater TH, Thomson D, Mack TG, Soffin EM, Mattison RJ, Coleman MP, et al. Age-dependent synapse withdrawal at axotomized neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. J Physiol 2002;543:739-755.
61. Guo ZH, Mattson MP. Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cereb Cortex 2000;10:50-57.
62. Mattson MP, Guo ZH, Geiger JD. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem 1999;73:532-537.
63. Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002;25:532-537.
64. Gillingwater TH, Ribchester RR. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J Neurocytol 2003;32:863-881.
65. Peters R. Ageing and the brain. Postgrad Med J 2006;82:84-88.
66. Goyns MH. Genes, telomeres and mammalian ageing. Mech Ageing Dev 2002;123:791-799.
67. Kirkwood TB. Time of our lives. What controls the length of life? EMBO Rep 2005;6:S4-8.
68. Kirkwood TB. Understanding the odd science of aging. Cell 2005;120:437-447.
69. Deary IJ, Wright AF, Harris SE, Whalley LJ, Starr JM. Searching for genetic influences on normal cognitive ageing. Trends Cogn Sci 2004;8:178-184.
70. Kachiwala SJ, Harris SE, Wright AF, Hayward C, Starr JM, Whalley LJ, et al. Genetic influences on oxidative stress and their association with normal cognitive ageing. Neurosci Lett 2005;386:116-120.
71. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
72. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, et al. Apolipoprotein e gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932. Psychol Aging 2004;19:367-371.
73. Brown DR. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J Neurosci Res 1999;58:717-725.
74. Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, et al. PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease. Ann Neurol 2003;53:409-412.
75. Golanska E, Hulas-Bigoszewska K, Rutkiewicz E, Styczynska M, Peplonska B, Barcikowska M, et al. Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD. Neurology 2004;62:313-315.
76. Knight RS, Will RG. Prion diseases. J Neurol Neurosurg Psychiat 2004;75(Suppl 1):i36-42.
77. Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Muller U, et al. Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 2004;63:364-366.
78. Deary IJ, Hamilton G, Hayward C, Whalley LJ, Powell J, Starr JM, et al. Nicastrin gene polymorphisms, cognitive ability level and cognitive ageing. Neurosci Lett 2005;373:110-114.
79. Deary IJ, Harris SE, Fox HC, Hayward C, Wright AF, Starr JM, et al. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci Lett 2005;378:22-27.
80. Harris SE, Wright AF, Hayward C, Starr JM, Whalley LJ, Deary IJ. The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds. Neurosci Lett 2005;385:1-6.
81. Wolkow CA. Life span: getting the signal from the nervous system. Trends Neurosci 2002;25:212-216.
82. Mattson MP. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2003;2:329-342.
83. Kyng KJ, Bohr VA. Gene expression and DNA repair in progeroid syndromes and human aging. Ageing Res Rev 2005;4:579-602.
84. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002;23:843-853.
85. Merry BJ. Molecular mechanisms linking calorie restriction and longevity. Int J Biochem Cell Biol 2002;34:1340-1354.
86. Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent tasting; two potential diets for successful brain aging. Ageing Research Reviews 2006;5:332-353.
87. Budge M, Johnston C, Hogervorst E, de Jager C, Milwain E, Iversen SD, et al. Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann NY Acad Sci 2000;903:407-410.
88. Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA 2004;101:2070-2075.
89. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 2003;26:81-104.
90. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002;25:295-301.
91. Shenkin SD, Bastin ME, MacGillivray TJ, Deary IJ, Starr JM, Wardlaw JM. Childhood and current cognitive function in healthy 80 year-olds: a DT-MRI study. NeuroReport 2003;14:345-349.
92. Staff RT, Murray AD, Deary IJ, Whalley LJ. What provides cerebral reserve? Brain 2004;127:1191-1199.
93. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mimics Z, Lee VM, et al. Environmental enrichment reduces Aβ levels and amyloid deposition in transgenic mice. Cell 2005;120:701-713.
94. Kyle D. The role of docosahexaenoic acid in the evolution and function of the human brain. In Brain Lipids and Disorders in Biological Psychiatry, Skinner E (ed.). Elsevier Science: Amsterdam, 2002; 1-22.
95. Elias MF, Robbins MA, Budge MM, Elias PK, Brennan SL, Johnston C, et al. Homocysteine, folate, and vitamins B6 and B12 blood levels in relation to cognitive performance: the Maine-Syracuse study. Psychosom Med 2006;68:547-554.
96. DeKosky ST. Statin therapy in the treatment of Alzheimer disease: what is the rationale? Am J Med 2005;118(Suppl 12A):48-53.
97. Di Monte DA. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2003;2:531-538.
98. Kisby GE, Ellison M, Spencer PS. Content of the neurotoxins cycasin (methylazoxymethanol β-D-glucoside) and BMAA (β-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology 1992;42:1336-1340.